University venture fund Osage University Partners backs Sideris Pharmaceuticals in $32m series A.

University of Florida spin-out Sideris Pharmaceuticals has completed a $32m series A round, led by MPM Capital. Joining the life science-focused venture firm in participation were Hatteras Venture Partners and Osage University Partners, a venture fund which represents over 60 US universities and research institutes. The life sciences firm was spun out from Florida earlier…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.